170 related articles for article (PubMed ID: 38317193)
1. Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
Pecci V; Troisi F; Aiello A; De Martino S; Carlino A; Fiorentino V; Ripoli C; Rotili D; Pierconti F; Martini M; Porru M; Pinto F; Mai A; Bassi PF; Grassi C; Gaetano C; Pontecorvi A; Strigari L; Farsetti A; Nanni S
Cancer Cell Int; 2024 Feb; 24(1):56. PubMed ID: 38317193
[TBL] [Abstract][Full Text] [Related]
2. H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer.
Bacci L; Aiello A; Ripoli C; Loria R; Pugliese D; Pierconti F; Rotili D; Strigari L; Pinto F; Bassi PF; Mai A; Grassi C; Pontecorvi A; Falcioni R; Farsetti A; Nanni S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426484
[TBL] [Abstract][Full Text] [Related]
3. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
5. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
[TBL] [Abstract][Full Text] [Related]
7. Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor-A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer.
Dalpatraj N; Naik A; Thakur N
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768182
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma.
Katagi H; Louis N; Unruh D; Sasaki T; He X; Zhang A; Ma Q; Piunti A; Shimazu Y; Lamano JB; Carcaboso AM; Tian X; Seluanov A; Gorbunova V; Laurie KL; Kondo A; Wadhwani NR; Lulla R; Goldman S; Venneti S; Becher OJ; Zou L; Shilatifard A; Hashizume R
Clin Cancer Res; 2019 Sep; 25(18):5572-5583. PubMed ID: 31227500
[TBL] [Abstract][Full Text] [Related]
9. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
Dalpatraj N; Naik A; Thakur N
Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
[TBL] [Abstract][Full Text] [Related]
10. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma.
Zhang Y; Wu W; Xu C; Yang H; Huang G
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):34. PubMed ID: 38393716
[TBL] [Abstract][Full Text] [Related]
12. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer.
Morozov VM; Li Y; Clowers MM; Ishov AM
Oncotarget; 2017 Sep; 8(37):62131-62142. PubMed ID: 28977932
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS Sensitizes Lung Adenocarcinoma to GSK-J4-Induced Metabolic and Oxidative Stress.
Hong BJ; Park WY; Kim HR; Moon JW; Lee HY; Park JH; Kim SK; Oh Y; Roe JS; Kim MY
Cancer Res; 2019 Nov; 79(22):5849-5859. PubMed ID: 31506334
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells.
Sui A; Xu Y; Li Y; Hu Q; Wang Z; Zhang H; Yang J; Guo X; Zhao W
Oncotarget; 2017 Sep; 8(40):68591-68598. PubMed ID: 28978140
[TBL] [Abstract][Full Text] [Related]
17. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
[TBL] [Abstract][Full Text] [Related]
18. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor.
Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation.
Song F; Zhang Y; Pan Z; Hu X; Yi Y; Zheng X; Wei H; Huang P
Cancer Cell Int; 2021 Oct; 21(1):559. PubMed ID: 34696780
[TBL] [Abstract][Full Text] [Related]
20. GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells.
Chu X; Zhong L; Yu L; Xiong L; Li J; Dan W; Ye J; Liu C; Luo X; Liu B
Cancer Cell Int; 2020; 20():209. PubMed ID: 32514253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]